| There is emerging evidence on the potential role of semaglutide in type 1 diabetes mellitus. |
| For this implication, we need to know which subgroups of subjects will benefit more. |
| There is also accumulating data on the role of semaglutide in non-alcoholic fatty liver and in non-alcoholic steatohepatitis. |
| Other potential therapeutic implications of semaglutide in kidney disease, in Alzheimer disease and potential secondary benefits on pulmonary diseases are also discussed. |
| Additional information and confirmation for these options is still needed. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.